A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study

计划入组 1,000 人 · 首次发布于 2018 年 12 月 7 日

A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

计划入组 382 人 · 首次发布于 2017 年 5 月 11 日

An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)

计划入组 49 人 · 首次发布于 2021 年 11 月 9 日

Cyclohexanediol(F. Hoffmann-La Roche Ltd.)

RO-51-32822(F. Hoffmann-La Roche Ltd.)

Malaria DNA vaccine(F. Hoffmann-La Roche Ltd.)

F. Hoffmann-La Roche Ltd

United States

F. Hoffmann-La Roche Ltd.

Switzerland

F. Hoffmann-La Roche AG

Switzerland

Roche Canada Secures Public Funding for Vabysmo in Quebec for Retinal Vein Occlusion Treatment

Roche Canada and pCPA Complete Negotiations for Perjeta in Neoadjuvant HER2-Positive Early Breast Cancer

La Roche-Posay Awards $50,000 to Eight Early-Career Dermatology Researchers in 2025 Young Investigator Grant